This article is part of a Chronicle. See more from this Chronicle
Elena Kamilarova, Dominik Schnichels, Feb 24, 2009
On November 28, 2008 the European Commission published its preliminary findings on the inquiry into the pharmaceutical sector in the European Union. The preliminary report shows that originator companies engage in practices that can contribute to a delay of generic entry. The report also found that originator companies use patent strategies aimed at blocking or delaying the develo
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.223.241.235
Please verify email or join us to access premium content!